Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Hannes BleulerOriginaire de Zollikon (ZH), Hannes Bleuler est né en 1954 au Maroc où il passa son enfance. Après la maturité latine a Zürich, il entre au Département d'électricité à l'ETHZ. Il obtient son diplôme en automatique, en 1978, et entre en fonction comme assistant à l'Institut de mécanique de la même école.
Il y participe à l'établissement du groupe de mécatronique et obtient son doctorat dans le domaine des paliers magnétiques actifs, activité qui mène à la fondation d'une compagnie avec des collègues et à un premier séjour de deux ans chez Hitachi au Japon.
De 1991 à 1995, il est d'abord Toshiba Professor of Intelligent Mechatronics à l'institut des sciences industrielles de l'Université de Tokyo et ensuite professeur associé régulier au département de microtechnique à cette même université.
Il y travaille en microtechnique (instrumentation) et robotique. A l'EPFL, ses activités se concentrent sur la robotique biomédicale et l'interface homme-machine (interfaces haptiques) et l'entraînement et la simulation de chirurgie. Il est directeur de la section microtechnique 2008-2009. Il anime les relations et les échanges entre l'EPFL et le Japon sur tous les niveaux et donne un cours (2010) sur l'histoire des sciences au Japon dans le cadre du Collège des Humanités.
Mohamed BouriDr. Mohamed Bouri is a group leader of Rehabilitation and Assistive Robotics in LSRO and lecturer of Robotics and Industrial Robotics. He graduated in Electrical Engineering in 1992 and obtained his PhD degree in 1997 in Industrial Automation at INSA LYON, France. Since 1997, he is at EPFL and is mainly active in the field of robot control, automation and robot design for medical and industrial applications. He is the head of Rehabilitation and Assistive Robotics group since 2005 and has strong references with the development of robotic devices for lower limb rehabilitation : The MotionMaker and WalkTrainer commercialzed by the company Swortec. His ongoing research currently focuses on the development of exoskeletons and the associated control strategies. His main current projects are TWIICE, a lower limb exoskeleton for people with paraplegia, AUTONOMYO, a walk assistance exoskeleton for people with muscle weakness, and the HiBSO, a hip orthosis for elderly.
Dominique PiolettiDominique Pioletti received his Master in Physics from the Swiss Federal Institute of Technology Lausanne (EPFL) in 1992. He pursued his education in the same Institution and obtained his PhD in biomechanics in 1997. He developed original constitutive laws taking into account viscoelasticity in large deformations. Then he spent two years at UCSD as post-doc fellow acquiring know-how in cell and molecular biology. He was interested in particular to gene expression of bone cells in contact to orthopedic implant. In April 2006, Dominique Pioletti was appointed Assistant Professor tenure-track at the EPFL and is director of the Laboratory of Biomechanical Orthopedics. His research topics include biomechanics and tissue engineering of musculo-skeletal tissues; mechano-transduction in bone; development of orthopedic implant as drug delivery system. Since 2013, he has been promoted to the rank of Associate Professor.